ATE326226T1 - Verwendung von methyltestosteron zur behandlung von menschlichen papillomavirus infektionen - Google Patents
Verwendung von methyltestosteron zur behandlung von menschlichen papillomavirus infektionenInfo
- Publication number
- ATE326226T1 ATE326226T1 AT03405852T AT03405852T ATE326226T1 AT E326226 T1 ATE326226 T1 AT E326226T1 AT 03405852 T AT03405852 T AT 03405852T AT 03405852 T AT03405852 T AT 03405852T AT E326226 T1 ATE326226 T1 AT E326226T1
- Authority
- AT
- Austria
- Prior art keywords
- methyltestosterone
- human papillomavirus
- treat human
- papillomavirus infections
- infections
- Prior art date
Links
- GCKMFJBGXUYNAG-UHFFFAOYSA-N 17alpha-methyltestosterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C)(O)C1(C)CC2 GCKMFJBGXUYNAG-UHFFFAOYSA-N 0.000 title abstract 2
- GCKMFJBGXUYNAG-HLXURNFRSA-N Methyltestosterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 GCKMFJBGXUYNAG-HLXURNFRSA-N 0.000 title abstract 2
- 208000009608 Papillomavirus Infections Diseases 0.000 title abstract 2
- 229960001566 methyltestosterone Drugs 0.000 title abstract 2
- 206010059313 Anogenital warts Diseases 0.000 abstract 1
- 241000934136 Verruca Species 0.000 abstract 1
- 208000000260 Warts Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 201000010153 skin papilloma Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021280789A CN1168449C (zh) | 2002-12-23 | 2002-12-23 | 抗人乳头瘤病毒感染的药物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE326226T1 true ATE326226T1 (de) | 2006-06-15 |
Family
ID=4745919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03405852T ATE326226T1 (de) | 2002-12-23 | 2003-12-01 | Verwendung von methyltestosteron zur behandlung von menschlichen papillomavirus infektionen |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040191311A1 (de) |
| EP (1) | EP1433481B1 (de) |
| CN (1) | CN1168449C (de) |
| AT (1) | ATE326226T1 (de) |
| DE (1) | DE60305279D1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1168449C (zh) * | 2002-12-23 | 2004-09-29 | 梁有国 | 抗人乳头瘤病毒感染的药物 |
| US7553825B2 (en) * | 2003-12-30 | 2009-06-30 | Gilead Sciences, Inc. | Anti-proliferative compounds, compositions, and methods of use thereof |
| AU2012200290B2 (en) * | 2005-10-19 | 2014-08-21 | Havah Therapeutics Pty Ltd | Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| CA2626337C (en) * | 2005-10-19 | 2015-12-29 | Chavah Pty Ltd | Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| RU2494732C1 (ru) * | 2012-07-03 | 2013-10-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Уральская государственная академия ветеринарной медицины" | Способ коррекции минерального обмена у коров в условиях биогеохимической провинции |
| CA2965372C (en) | 2014-10-22 | 2023-09-05 | Havah Therapeutics Pty Ltd | Methods of reducing mammographic breast density and/or breast cancer risk |
| CA3002562A1 (en) | 2015-10-22 | 2017-04-27 | Havah Therapeutics Pty Ltd | Methods of reducing mammographic breast density and/or breast cancer risk |
| CN114599369B (zh) | 2019-06-03 | 2026-02-10 | 哈瓦赫治疗有限公司 | 用于递送雄激素剂和芳香酶抑制剂的药物制剂和系统以及使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3514724A1 (de) * | 1985-04-24 | 1986-10-30 | Albin F. Dr. 4200 Oberhausen Jereb | Salbe zur verbeugung und behandlung von augen- und hauterkrankungen |
| US4605648A (en) * | 1985-08-15 | 1986-08-12 | Price E Pendleton | Treatment of Herpes Simplex viruses |
| US20030060435A1 (en) * | 1994-05-31 | 2003-03-27 | Serge Carillo | Method of cancer treatment by p53 protein control |
| CN1168449C (zh) * | 2002-12-23 | 2004-09-29 | 梁有国 | 抗人乳头瘤病毒感染的药物 |
-
2002
- 2002-12-23 CN CNB021280789A patent/CN1168449C/zh not_active Expired - Fee Related
-
2003
- 2003-12-01 EP EP03405852A patent/EP1433481B1/de not_active Expired - Lifetime
- 2003-12-01 AT AT03405852T patent/ATE326226T1/de not_active IP Right Cessation
- 2003-12-01 DE DE60305279T patent/DE60305279D1/de not_active Expired - Lifetime
- 2003-12-05 US US10/729,624 patent/US20040191311A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1168449C (zh) | 2004-09-29 |
| CN1424040A (zh) | 2003-06-18 |
| DE60305279D1 (de) | 2006-06-22 |
| EP1433481A1 (de) | 2004-06-30 |
| EP1433481B1 (de) | 2006-05-17 |
| US20040191311A1 (en) | 2004-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60320007D1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| ATE292971T1 (de) | (s,s)-reboxetin zur behandlung von peripheren neuropathien | |
| DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| ATE408601T1 (de) | Fredericamycin-derivate | |
| DE602004028763D1 (de) | Te zur behandlung von virenerkrankungen | |
| DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| DE60230759D1 (de) | Krillextrakte zur prävention und/oder behandlung von herz-kreislauf-erkrankungen | |
| NO20061122L (no) | 2-(Quinoksalin-5-ylsuflonylamino)-benzamid forbindelser som CCK2 modulatorer | |
| ATE451921T1 (de) | Phenylindole zur behandlung von hiv | |
| WO2006015035A8 (en) | Useful compounds for hpv infection | |
| ATE521361T1 (de) | Verfahren zur behandlung von gebärmutterhalskrebs | |
| DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
| ATE443704T1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| ATE420099T1 (de) | Medikament zur wachstumsinhibierung von tumoren | |
| NO20055741D0 (no) | Nye kjemiske forbindelser | |
| ATE281432T1 (de) | C-16 ungesätigte fp-selektive prostaglandin analoge | |
| DE60305279D1 (de) | Verwendung von Methyltestosteron zur Behandlung von menschlichen Papillomavirus Infektionen | |
| ATE289196T1 (de) | Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen | |
| DE602004019778D1 (de) | Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen | |
| DE602005014632D1 (de) | Pyrrol- bzw. imidazolamide zur behandlung von obesitas | |
| CY1110156T1 (el) | Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης | |
| EA200600115A1 (ru) | Производные 2-аминобензойной кислоты | |
| DE60124093D1 (de) | S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen. | |
| DE60326348D1 (de) | Makrozyclen zur behandlung von krebserkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |